Vial fogging is a phenomenon commonly observed in lyophilized biologic drug products and has been widely reported in the pharmaceutical industry. The appearance of vial fogging presents as a haze…
The presentation will discuss the advantages and disadvantages of foam drying, such as improved storage stability of pharmaceutical products at increased temperatures, faster drying cycles, and better preservation of biologic…
In the freeze drying world, most of the work and literature published is related to vial freeze drying and does not touch on some of the differences that are only…
Accelerate your lyophilized drug development by de-risking your primary packaging selection. Physical and chemical properties of a container closure system for parenterals may affect the drug manufacturing process, product quality…
The emergence of cell and gene therapies and new COVID-19 vaccines brings the promise of treating some of the most challenging diseases. Storage, transport, and delivery of these breakthrough therapies…
Antibody drug conjugates (ADCs) are antibodies equipped with a small number of chemotherapeutic molecules with the aid of a linker system. They have grown in importance because the antibody targets…
This webinar will demonstrate how the MicroFD with LyoPAT can be used to both develop an optimized lyophilization protocol and then transfer the protocol to a pilot or production scale…
Due to the product pre-conditioning in individual vials, freeze-drying process can be difficult to design and often results in batches presenting a significant heterogeneity in the quality of the final…
The purpose of this webinar is to describe the types of in-process data that can be collected and provide examples of their use. In-process data collected at full-scale are valuable…
MicroFD® is a small-scale freeze-dryer where very few vials are loaded: it allows tremendous API savings, beside shortening the stages of batch preparation & loading, condenser defrosting, etc.
- « Previous
- 1
- 2
- 3
- Next »
